Added to YB: 2026-08-11
Pitch date: 2026-08-07
NOVO-B.CO [neutral]
Novo Nordisk A/S
+1.55%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products.
Market Cap
DKK 1.3T
Pitch Price
DKK 47.00
Price Target
N/A
Dividend
3.83%
EV/EBITDA
8.24
P/E
11.65
EV/Sales
4.39
Sector
Pharmaceuticals
Category
growth
Show full summary:
Theodosian Capital | Stocks Update 7/8/2026 - NOVOB – Rare good news
NOVO-B.CO (earnings): Q2 reported sales +3% CER (+7% adj); reported op profit -16% (hit by prior-yr one-offs + DKK6.3bn impairment), adj op profit +11% CER. Wegovy rollouts in UAE/UK show encouraging uptake. FY guide raised to 0% to -6% (from -4% to -12%). 13.5x 2028 EPS, 3.9% yield.
Read full article (1 min)